FMS样酪氨酸激酶3(Flt3)重组蛋白
Recombinant FMS Like Tyrosine Kinase 3 (Flt3)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
Organism species
|
Homo sapiens (Human)
|
Product No.
|
KL039Hu01
|
Source
|
Prokaryotic expression
|
Host
|
E.coli
|
Purity
|
> 95%
|
UOM
|
50ug
|
Predicted Molecular Mass
|
26.9kDa
|
Concentration
|
8.3
|
Applications
|
SDS-PAGE; WB; ELISA; IP.
|
Endotoxin Level
|
<1.0EU per 1µg (determined by the LAL method)
|
Residues
|
Lys334~Ser543 (Accession # P36888) with two N-terminal Tags, His-tag and T7-tag
|
Formulation
|
Supplied as lyophilized form in PBS, pH7.4, containing 5% trehalose, 0.01% sarcosyl.
|
FMS样酪氨酸激酶3(Flt3)重组蛋白SEQUENCES
The sequence of the target protein is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- KHPSQSA LVTIVEKGFI NATNSSEDYE IDQYEEFCFS VRFKAYPQIR CTWTFSRKSF PCEQKGLDNG YSISKFCNHK HQPGEYIFHA ENDDAQFTKM FTLNIRRKPQ VLAEASASQA SCFSDGYPLP SWTWKKCSDK SPNCTEEITE GVWNRKANRK VFGQWVSSST LNMSEAIKGF LVKCCAYNSL GTSCETILLN SPGP NIS
FMS样酪氨酸激酶3(Flt3)重组蛋白USAGE
Reconstitute in sterile ddH2O.
FMS样酪氨酸激酶3(Flt3)重组蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
FMS样酪氨酸激酶3(Flt3)重组蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL394Hu02 组织因子通道抑制因子(TFPI)重组蛋白 Recombinant Tissue Factor Pathway Inhibitor (TFPI) Homo sapiens (Human)
KL929Hu02 Vav3癌基因(VAV3)重组蛋白 Recombinant Vav 3 Oncogene (VAV3) Homo sapiens (Human)
KL079Mu01 碳酸酐酶Ⅻ(CA12)重组蛋白 Recombinant Carbonic Anhydrase XII (CA12) Mus musculus (Mouse)
KL071Mu01 碳酸酐酶Ⅳ(CA4)重组蛋白 Recombinant Carbonic Anhydrase IV (CA4) Mus musculus (Mouse)
KL548Mu02 细胞间粘附分子1(ICAM1)重组蛋白 Recombinant Intercellular Adhesion Molecule 1 (ICAM1) Mus musculus (Mouse)
KL637Mu02 氨基己糖苷酶Bβ(HEXβ)重组蛋白 Recombinant Hexosaminidase B Beta (HEXb) Mus musculus (Mouse)
KL638Mu01 白介素10受体β(IL10Rβ)重组蛋白 Recombinant Interleukin 10 Receptor Beta (IL10Rb) Mus musculus (Mouse)
KL771Mu01 白介素11受体α(IL11Rα)重组蛋白 Recombinant Interleukin 11 Receptor Alpha (IL11Ra) Mus musculus (Mouse)
KL771Mu02 白介素11受体α(IL11Rα)重组蛋白 Recombinant Interleukin 11 Receptor Alpha (IL11Ra) Mus musculus (Mouse)
KL073Mu01 白介素12受体β2(IL2Rβ2)重组蛋白 Recombinant Interleukin 12 Receptor Beta 2 (IL12Rb2) Mus musculus (Mouse)
KL073Mu02 白介素12受体β2(IL2Rβ2)重组蛋白 Recombinant Interleukin 12 Receptor Beta 2 (IL12Rb2) Mus musculus (Mouse)
KL655Mu02 白介素18受体辅助蛋白(IL18RAP)重组蛋白 Recombinant Interleukin 18 Receptor Accessory Protein (IL18RAP) Mus musculus (Mouse)